| Rubicon Research Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544578 |
NSE Symbol : RUBICON |
P/E(TTM) : 80.14 |
|
ISIN Demat : INE506V01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 9.62 |
|
Book Value(₹) : 76.31 |
Market Cap(₹Cr) : 12,701.43 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 301.71 | 336.47 | 278.03 | 300.81 | 244.87 | 254.90 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 301.71 | 336.47 | 278.03 | 300.81 | 244.87 | 254.90 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.30 | 1.51 | 1.44 | 11.97 | 2.33 | 2.82 |
| Total Income | 306.01 | 337.98 | 279.46 | 312.78 | 247.20 | 257.72 |
| Total Expenditure | 239.46 | 257.37 | 214.89 | 239.50 | 180.97 | 186.49 |
| PBIDT | 66.55 | 80.61 | 64.58 | 73.27 | 66.24 | 71.23 |
| Interest | 7.51 | 9.21 | 8.85 | 10.78 | 7.25 | 6.38 |
| PBDT | 59.04 | 71.41 | 55.73 | 62.50 | 58.99 | 64.85 |
| Depreciation | 9.51 | 9.78 | 8.30 | 8.57 | 7.93 | 7.32 |
| Tax | 10.12 | 19.12 | 10.05 | 11.32 | 16.78 | 15.30 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.23 | -3.30 | 2.23 | 2.34 | -3.95 | -0.65 |
| Reported Profit After Tax | 37.18 | 45.81 | 35.15 | 40.27 | 38.23 | 42.89 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 37.18 | 45.81 | 35.15 | 40.27 | 38.23 | 42.89 |
| EPS (Unit Curr.) | 2.28 | 2.97 | 2.28 | 2.61 | 2.51 | 2.82 |
| EPS (Adj) (Unit Curr.) | 2.28 | 2.97 | 2.28 | 2.61 | 2.51 | 2.82 |
| Calculated EPS (Unit Curr.) | 2.26 | 2.97 | 2.28 | 2.61 | 2.51 | 2.78 |
| Calculated EPS (Adj) (Unit Curr.) | 2.26 | 2.97 | 2.28 | 2.61 | 2.51 | 2.78 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.03 | 11.87 | 9.12 | 10.45 | 10.05 | 11.13 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.03 | 11.87 | 9.12 | 10.45 | 10.05 | 11.13 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.48 | 15.44 | 15.41 | 15.41 | 15.21 | 15.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.06 | 23.96 | 23.23 | 24.36 | 27.05 | 27.94 |
| PBDTM(%) | 19.57 | 21.22 | 20.04 | 20.78 | 24.09 | 25.44 |
| PATM(%) | 12.32 | 13.61 | 12.64 | 13.39 | 15.61 | 16.83 |